<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
__________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 30, 1996
------------
The Female Health Company
-------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Wisconsin
-------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-18849 39-1144397
- ------------------------ -----------------------------
(Commission File Number) (I.R.S. Employer I.D. Number)
919 North Michigan Avenue
Suite 2208
Chicago, Illinois 60611
- ------------------------------- -----------------------------
(Address of Principal Executive (Zip Code)
Offices)
312-280-2281
-------------------------------------------------------------------
(Registrant's telephone number; including area code)
N/A
-------------------------------------------------------------------
(Former Name or Former Address if Changed Since Last Report)
<PAGE>
Item 4. Changes In Registrant's Certifying Accountant.
- ------------------------------------------------------
As previously reported, in February 1996, the Board of Directors of The
Female Health Company (the "Company") decided to seek competitive bids for the
Company's outside accounting work from various independent auditors. During
this process, Ernst & Young LLP, the former independent auditors for the Company
("Ernst & Young"), formally resigned as independent auditors of the Company on
February 21, 1996.
After discussions with various firms, on May 30, 1996, the Company engaged
the firm of McGladrey & Pullen, LLP as the Company's independent auditors for
the 1996 fiscal year.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
THE FEMALE HEALTH COMPANY
Date: May 30, 1996
/s/ O.B. Parrish
BY________________________________________
O.B. Parrish, Chairman and Chief
Executive Officer
